1. Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD? 
Amalia Gastaldelli, Giulio Marchesini 
Journal of Hepatology 
Volume 64, Issue 2, Pages (February 2016)
DOI: /j.jhep
Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Schematic representation of the mechanisms explaining the metabolic effects of liraglutide leading to an improvement in hepatic parameters. DNL, de novo lipogenesis; FFA, free fatty acids; GLP-1, glucagon-like peptide-1; GNG, gluconeogenesis; MCP-1, monocyte chemoattractant protein-1.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2015 European Association for the Study of the Liver Terms and Conditions